Genspect

Genspect is an international gender-critical advocacy organization founded in June 2021 by Irish psychotherapist and author Stella O'Malley. The organization describes itself as a network of parents, educators, counselors, clinicians, detransitioners, and other people concerned about contemporary approaches to gender dysphoria and transgender healthcare. Its work focuses primarily on children and adolescents, although statements by people associated with the organization have also discussed restrictions on transition for adults. The organization's central position is opposition to what it calls a gender-affirming or affirmative model of care. Genspect argues that children and young people who question their gender should receive extensive psychological exploration and assessment rather than rapid access to social or medical transition. It has opposed puberty blockers, cross-sex hormones, and transition-related surgery for minors, and has argued against permitting people under 25 to transition. Genspect also supports the use of the disputed term rapid-onset gender dysphoria, or ROGD, to describe some adolescent gender questioning. Major medical and psychiatric bodies do not recognize ROGD as a valid diagnosis and have criticized the evidentiary basis of the concept. Genspect's advocacy extends beyond clinical policy. It has supported parents who object to schools using a child's chosen name or pronouns without parental knowledge, advised schools and families on social transition, and opposed practices such as chest binding and tucking in school settings. It has intervened in or supported legal and policy disputes involving transgender healthcare, education, conversion-therapy legislation, legal gender recognition, and public funding of transition-related care. The organization has also organized conferences and online events focused on detransition, gender medicine, and ROGD. Genspect is closely associated with the Society for Evidence-Based Gender Medicine, commonly known as SEGM. Several people described as SEGM advisers have also worked with or advised Genspect, including O'Malley and clinical adviser Lisa Littman. The relationship has contributed to Genspect's influence within a wider network of gender-critical organizations, clinicians, campaigners, and parent groups in Europe and North America. The organization has attracted substantial criticism from transgender-rights groups, professional medical organizations, journalists, and researchers. Critics argue that its positions conflict with the prevailing guidance of bodies including the World Professional Association for Transgender Health, the Endocrine Society, the American Psychiatric Association, the American Psychological Association, and the American Academy of Pediatrics. These organizations generally support individualized, evidence-based gender-affirming care where clinically indicated. The Southern Poverty Law Center designated Genspect and SEGM as anti-LGBTQ hate groups in 2023, a characterization the organizations reject. Genspect has also been accused of promoting conversion practices through its advocacy of so-called exploratory therapy, while it maintains that exploratory therapy is distinct from coercive attempts to change a person's gender identity. Genspect has no publicly documented stock listing, parent company, or commercial product portfolio. Its activities are principally advocacy, public education, policy intervention, conferences, media commentary, and support for parents and professionals who oppose gender-affirming approaches. Its website remains the principal public platform for its publications, events, and organizational material.

Genspect was founded in June 2021 by psychotherapist Stella O'Malley. Its public launch was framed around concerns that children questioning their gender were being directed toward medical treatment too quickly and without sufficient consideration of mental-health history, autism, trauma, family circumstances, and other factors. The organization emerged within a broader international gender-critical movement that challenged the use of affirmative models for transgender and gender-questioning young people. Soon after its launch, Genspect became involved in disputes about schools and parental authority. It supported a legal case in Wales concerning the use of a student's preferred pronouns without the parent's knowledge and subsequently advised parents and schools that social transition should not occur without parental involvement. Its guidance has opposed the use of chosen names and pronouns in some circumstances and has recommended restrictions on tucking and chest binding in schools. The organization also entered litigation and legislative debates concerning access to medical transition. In July 2021 it intervened in an Arizona case involving Medicaid coverage for transgender healthcare. It later opposed California Senate Bill 107, which was designed to provide refuge to transgender children and families from states pursuing restrictive policies. In Europe, Genspect joined organizations supporting a proposed European ban on medical transition for minors, linking the proposal to the contested ROGD hypothesis. A major part of Genspect's intellectual and public program has been the promotion of ROGD. The concept proposes that some adolescents develop gender dysphoria through peer influence or social contagion. Genspect organized a 2021 online meeting on the theory and has continued to present it in its advocacy. The hypothesis is not recognized as a medical diagnosis by major professional associations, and critics have argued that its underlying research has methodological limitations and may stigmatize transgender adolescents and gender-affirming care. Genspect has also campaigned against laws prohibiting conversion practices when those laws include attempts to change or suppress gender identity. O'Malley has promoted the term exploratory therapy, arguing that clinicians should be able to investigate the causes and meaning of gender distress. Critics, including commentators in evidence-based medicine, have argued that the terminology could provide a more acceptable label for coercive or change-oriented practices. Genspect has denied that it supports conversion therapy and has distinguished its proposed approach from efforts to force a patient to adopt a particular identity. In 2022, Genspect opposed proposed Scottish reforms that would have simplified legal gender recognition and participated in opposition to Drag Queen Story Hour events. It also held a Detrans Awareness Day and criticized claims that transition regret was rare or negligible. The organization challenged the American Academy of Pediatrics' gender-care policy through support for Resolution 27, a proposal calling for reconsideration of hormone therapy as an initial treatment and a new evidence review. The AAP said the resolution did not pass because it lacked sufficient support and maintained that its guidance was undergoing routine review. Genspect criticized the eighth edition of the World Professional Association for Transgender Health's Standards of Care, particularly its provisions concerning adolescent treatment and parental involvement. In 2023, it held a conference in Killarney alongside a separate conference by the European Professional Association of Transgender Health, with the events representing opposing perspectives on transgender healthcare. Leaked material from a Genspect-operated online community was also reported in 2023; the material was cited in coverage of the organization's views about pornography, adolescent gender identity, and its stated opposition to transition for minors. Genspect remains an advocacy and information organization rather than a conventional commercial brand. Its activities include policy submissions, public letters, conferences, media appearances, online resources, and support for parents and professionals opposed to gender-affirming approaches. Its close links with SEGM and its criticism by major medical organizations and LGBTQ-rights groups have made it a prominent and controversial participant in international debates over transgender healthcare and youth policy.

• 2023

  Killarney conferences

  [1]Genspecten.wikipedia.org

  Genspect held a conference in Killarney addressing transgender healthcare and gender-critical policy arguments.

• 2023

  SPLC designation

  [1]Genspecten.wikipedia.org

  The Southern Poverty Law Center designated Genspect and SEGM as anti-LGBTQ hate groups.

• 2022

  Detrans Awareness Day

  [1]Genspecten.wikipedia.org

  Genspect held an event focused on detransition and transition regret on 12 March.

• 2022

  AAP Resolution 27 debate

  [1]Genspecten.wikipedia.org

  Genspect-associated physicians supported a failed American Academy of Pediatrics resolution seeking reconsideration of the organization's gender-care guidance.

• 2021

  Organization founded

  [1]Genspecten.wikipedia.org

  Stella O'Malley founded Genspect in June as an international gender-critical advocacy organization.

• 2021

  First ROGD-focused online meeting

  [1]Genspecten.wikipedia.org

  Genspect organized an online meeting on rapid-onset gender dysphoria featuring Lisa Littman, David Bell, and Stella O'Malley.

Gender-critical advocacy organization opposing routine or affirmative approaches to social and medical transition, particularly for children and adolescents, and promoting psychological exploration and parental involvement.

• Advocacy resources · 2021

  Genspect educational and policy materials

  Genspect publishes online commentary, policy arguments, parent guidance, and professional-facing material concerning gender dysphoria, social transition, medical transition, detransition, and education. These materials generally promote a gender-critical framework, emphasize psychological exploration and parental involvement, and criticize affirmative clinical models.

• Events · 2021

  Genspect conferences and webinars

  The organization runs or supports conferences, webinars, and public meetings featuring clinicians, researchers, parents, detransitioners, and campaigners. Topics have included rapid-onset gender dysphoria, detransition, conversion-therapy legislation, and the regulation of gender medicine.

• 2023

  Promotion of disputed rapid-onset gender dysphoria theory

  Genspect has promoted ROGD, a concept not recognized as a diagnosis by major professional organizations and criticized for insufficient evidence and potential stigmatizing effects.

  Source

• 2023

  SPLC anti-LGBTQ hate-group designation

  The Southern Poverty Law Center designated Genspect and SEGM as anti-LGBTQ hate groups. Genspect rejects the designation.

  Source

• 2023

  Claims about Boston Children's Hospital

  Genspect promoted claims that Boston Children's Hospital performed vaginoplasty on minors; reporting cited in the reference material states that no such surgeries were performed. The organization did not issue an apology and defended its interpretation of adolescence.

  Source

• 2023

  Leaked online-community discussions

  Reportedly leaked chat logs from a Genspect-operated Discord community were cited in coverage of statements about pornography, adolescent gender identity, and the organization's opposition to transition for minors.

  Source

Read more

• 2022Opposition to California Senate Bill 107

  United States

  Genspect campaigned against California legislation intended to protect transgender children and families seeking refuge from restrictive policies elsewhere.

  Source
• 2022Opposition to conversion-therapy legislation

  New Zealand · Ireland · United Kingdom

  Genspect opposed provisions that would prohibit practices aimed at changing or suppressing gender identity, arguing that exploratory therapy should remain lawful.

  Source
• 2022Detrans Awareness Day

  International

  Genspect organized a public event highlighting detransition experiences and challenging claims that transition regret is uncommon.

  Source
• 2022Opposition to Drag Queen Story Hour

  United Kingdom

  Genspect and the Family Education Trust signed a letter opposing Drag Queen Story Hour events in primary schools on age-appropriateness grounds.

  Source
• 2021Challenge to gender-affirming care for youth

  United Kingdom · United States · International

  Genspect launched with advocacy against rapid access to social and medical transition for children and adolescents, emphasizing assessment of co-occurring conditions and family context.

  Source
• 2021Arizona Medicaid case intervention

  United States

  Genspect intervened in litigation defending Arizona's exclusion of transgender healthcare from Medicaid coverage.

  Source

• 2022

  Challenge to American Academy of Pediatrics policyOther

  Background

  Genspect-associated physicians argued that the AAP should reconsider its 2018 approach to gender-affirming care and conduct a systematic evidence review.

  Action taken

  They supported Resolution 27 and later requested a non-partisan review of the AAP's guidance.

  Aftermath

  The resolution failed to pass. The AAP said its process had operated normally and that its guidance was already subject to routine review.

  • American Academy of Pediatrics — The AAP rejected the characterization that its standards were being improperly blocked and defended evidence-based gender-affirming care.

  Source

• 2022

  Opposition to WPATH Standards of Care 8Strategy

  Background

  Genspect objected to provisions addressing adolescent treatment, parental involvement, and gender-related care.

  Action taken

  The organization publicly criticized the updated standards and warned against their clinical and cultural implications.

  Aftermath

  WPATH's standards remained influential among specialist clinicians, while Genspect continued campaigning against them.

  • World Professional Association for Transgender Health — WPATH issued and maintained its updated standards, which support individualized care and recommend parental involvement unless involvement would be harmful or infeasible.

  Source

• 2021

  Focus advocacy on people under 25Strategy

  Background

  Genspect publicly concentrated its political messaging on restrictions affecting people under 25, while an associated vice director described this as a strategy for reaching policymakers who might not support broader restrictions.

  Action taken

  The organization made opposition to youth transition a central policy and communications priority.

  Aftermath

  The strategy helped place Genspect in debates over youth healthcare, education, and legal recognition, while critics argued that it concealed a broader opposition to transition at any age.

  Source

1. 1Genspecten.wikipedia.org
2. 2Genspect official websitegenspect.org